Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2025 May 21;135(9):3213–3221. doi: 10.1002/lary.32182

Impact of WPOI‐5 on Risk of Regional Recurrence in Early Oral Cancer With pN0 Neck

Justin Hintze 1, Nadia van den Berg 1, Deirdre Callanan 1, Shima Mohamed 2, Linda Feeley 2,3, Patrick Sheahan 1,3,4,
PMCID: PMC12371855  PMID: 40396632

ABSTRACT

Introduction

Regional recurrence (RR) has been reported to occur in 7%–17% of patients with oral squamous cell carcinoma (OSCC) and pathologically negative (pN0) necks. Risk factors for isolated RR, in the absence of simultaneous local recurrence, are poorly defined. Our aim was to study risk factors for isolated RR in early OSCC with clinically and pathologically negative necks.

Methods

Retrospective cohort study of 202 patients with cT1/2N0 OSCC.

Results

Among 130 patients undergoing elective neck dissection, 98 were pN0. Five (5.1%) developed isolated RR, and 7 (7.1%) developed any RR. Risk factors for isolated RR were worst pattern of invasion category 5 (WPOI‐5) (p = 0.02), and absence of postoperative radiotherapy (PORT) (p = 0.04). Among 170 patients with pN0 or cN0/x necks, risk factors for isolated RR were WPOI‐5 and depth of invasion > 10 mm. On multivariate analysis, only WPOI‐5 remained significant.

Conclusion

Isolated RR may occur in over 5% of patients with early OSCC and pathologically negative necks after elective ND. WPOI‐5 would appear to be the most important risk factor for isolated RR in pN0 cases. Further work is required to define the role of PORT in patients with WPOI‐5.

Level of Evidence

3.

Keywords: elective neck dissection, head and neck, neck, neck dissection, oral cavity, pN0, squamous cell carcinoma, WPOI‐5


In the present retrospective study, worst pattern of invasion category 5 (WPOI‐5) was found to be significantly associated with regional recurrence (RR) among patients with early oral cancer and pathologically negative necks after elective neck dissection. Isolated RR was seen only among patients not receiving postoperative radiotherapy (PORT), however, more work is required to define the role of PORT in patients with WPOI and pN0 necks.

graphic file with name LARY-135-3213-g001.jpg

1. Introduction

The presence of lymph node metastases is well established as one of the most important adverse prognostic factors in oral cavity squamous cell carcinoma (OSCC) [1, 2]. Among patients presenting with clinically negative necks (cN0), elective neck dissection (ND) is generally recommended, as this provides not only prognostic information to help stratify patients for adjuvant treatment [3], but may also provide a survival benefit for patients with occult metastases [4, 5]. Besides nodal metastases, other factors that have been described as adverse prognosticators in OSCC include depth of invasion (DOI) [6, 7], perineural invasion (PNI) [8, 9], lymphovascular invasion (LVI) [10, 11], positive surgical margins [12, 13, 14], and histological pattern of invasion (POI) at the invasive front [8, 11, 15, 16, 17, 18]. Regarding the latter, Brandwein‐Gensler described five categories of POI, with worst pattern of invasion‐5 (WPOI‐5) being of most relevance [8]. WPOI‐5 is defined according to the College of American Pathologists as ≥ 1 mm dispersion between tumor satellites, and/or extratumoral LVI or PNI [19]. This differs somewhat from the POI definition utilized by the Royal College of Pathologists (RCPath), which is now a tertiary system in their updated 2023 guidelines, and classifies the invasive front as cohesive, non‐cohesive, or the newly introduced category of widely dispersed. Using this approach, cohesive is equivalent to WPOI patterns 1–3, non‐cohesive to WPOI‐4, and widely dispersed to WPOI‐5 [20].

Among patients with cN0 necks undergoing elective ND without pathological evidence of nodal metastases (pN0), prognosis is considered favorable, and the risk of regional recurrence (RR) is generally considered to be low. However, RR in patients who are pN0 after elective ND (END) is described. In a recent systematic review and meta‐analysis, Chegini et al. reported RR to occur in the pN0 neck in 17.3% of cases staged T1‐4, and in 7.5% of cases staged T1/2 [21]. However, there are little published data regarding risk factors for RR among patients who are pN0 following elective clearance of the nodal basin.

The primary aim of the present study was thus to study the incidence of and risk factors for RR in pN0 neck among patients with early OSCC. A secondary aim was to investigate risk factors for the finding of occult metastases in the cN0 neck.

2. Methods

This was a retrospective cohort study of a prospectively maintained database of oral cavity squamous cell carcinomas in a regional referral center for head and neck cancer between 2000 and 2021. The study was performed according to STROBE reporting guidelines. Ethical approval was granted by the Cork Clinical Research Ethics Committee. Inclusion criteria were new cases of T1 and T2 OSCC (7th edition AJCC staging), with cN0 at presentation, undergoing primary surgical treatment. Exclusion criteria included a previous history of head and neck cancer or radiotherapy (RT) to the neck.

Patient files were reviewed and data collected including demographics and clinical characteristics, type of surgery performed, and administration of adjuvant treatment. Clinical nodal status of the neck (cN+ versus cN0) was determined by review of notes and original radiology reports. Pathological data recorded included tumor size, DOI, POI, PNI, LVI, and margin status. Although inclusion criteria for the present study were based on the 7th edition AJCC staging, all patients were re‐staged according to the AJCC 8th edition. Of note, DOI measurements were previously re‐evaluated for all patients in our study cohort who underwent surgery prior to the issuance by the AJCC in 2017 of the clarified definition for this parameter. Slide review was also performed among cases reported as having a non‐cohesive POI, PNI, or LVI, to ascertain if satellite nodules and/or extratumoral PNI or LVI, fulfilling the definition for WPOI‐5, were present. Of note, cases reported as having non‐cohesive growth on initial reports incorporated both WPOI‐4 and WPOI‐5 cases, as, at that time, the RCPath utilized a two‐tier system of cohesive versus non‐cohesive only for assessing POI. Slide review was undertaken by two pathologists at a multiheaded microscope and consensus results recorded. Extratumoral PNI and extratumoral LVI were defined as PNI or LVI present ≥ 1 mm beyond the invasive tumor front, respectively. WPOI‐5 was defined as dispersed satellite nodule(s) ≥ 1 mm from the main tumor or presence of extratumoral PNI or LVI. Positive margins were defined as invasive SCC or carcinoma in situ at the margin.

At our institution, ND is generally performed as default among patients with early OSCC, excepting cases of very thin (< 3 mm) primary tumors or with significant comorbidity. For tumors approaching midline, bilateral ND is performed. Decisions regarding postoperative RT (PORT) are made at the Head & Neck multidisciplinary meeting. General indications for PORT include positive margins or the presence of nodal metastases. Relative indications include the presence of very close margins, PNI, or large primary tumors (pT3/4).

3. Outcomes Measures

The primary outcome measure was the incidence of isolated RR among patients with pN0 necks. Secondary outcome measures included the incidence of and risk factors for occult metastases detected by pathological examination of the cN0 neck among patients undergoing elective ND. Due to the small number of events of isolated RR among patients with pN0 necks, we also performed an analysis of the incidence of any RR in this cohort, as well as an analysis of the risk of isolated or any RR among patients with pN0/x necks. Isolated RR was defined as RR occurring in the absence of preceding or concomitant local recurrence (LR) or secondary primary tumor (SPT). RR‐free survival was defined as the time period between the date of surgery and the date of diagnosis with RR or last follow‐up in clinic. Patients developing head and neck SPTs were censored at the time of presentation with the SPT.

4. Data Analysis

Statistical analysis was performed using IBM SPSS version 26. Comparisons of categorical data were made using crosstabs with either chi‐squared test or Fisher's exact test if cell numbers were below 10. Post hoc analysis between groups was performed using Bonferroni correction, where applicable. 5‐year overall survival (OS) and disease‐specific survival (DSS) were computed using the Kaplan–Meier method and compared using log‐rank test. Univariate and multivariate Cox regression analyses were performed to determine factors associated with DSS and OS. Variables deemed clinically relevant or statistically significant on univariate Cox regression analysis were included in multivariate Cox regression analysis. A backwards stepwise entry method with p > 0.1 as an exclusion criterion was used for multivariate analysis.

5. Results

202 (132 male) patients with cT1/2N0 oral cavity SCC were identified. Mean age was 62.9 ± 13.3 years. Primary tumor subsites were tongue (101, 50%), floor of mouth (52, 25.7%), buccal mucosa (11, 5.4%), lower alveolus (16, 7.9%), retromolar trigone (12, 5.9%), lip (6, 3%), upper alveolus (3, 1.5%), and hard palate (1, 0.5%). 130 patients underwent unilateral (105) or bilateral (25) ND. The mean lymph node yield per hemineck was 24.9 ± 11.8.

5.1. Recurrences in pN0 Patients

Ninety‐eight patients were pN0 after ND. Demographic and clinicopathological data of this cohort are shown in Table 1. Mean (median) follow‐up was 72 (60) months. 7 (7.1%) patients developed RR, of whom two had RR simultaneous with local recurrence (LR), giving 5 (5.1%) patients with isolated RR. Three patients with isolated RR had recurrence in the contralateral undissected neck. Of the two patients with simultaneous LR and RR, one had RR in the contralateral undissected neck, and the other had bilateral neck recurrence. Of note, none of the patients with isolated RR had received PORT.

TABLE 1.

Clinicopathological characteristics of patients who were pN0 or pNx.

pN0 (n = 98) pNx (n = 72)
Age (years) 59.1 68.2 < 0.0001
Sex Male 57 52 0.08
Female 41 20
Site Tongue 53 31 0.17 (tongue v non‐tongue)
Floor of mouth 26 17
Lower alveolus 6 9
Retromolar 5 6
Upper alveolus/hard palate 2 1
Buccal 6 4
Lip 0 4
Neck dissection None 0 72
Unilateral 80 0
Bilateral 18 0
DOI (mm) 7.42 4.76 0.0007

T‐classification

(AJCC 8th edition)

pT1 26 46 < 0.0001 (pT1 v pT2/3)
pT2 59 21
pT3 13 5
Invasive front Cohesive 55 62 < 0.0001
Non‐cohesive 43 10
PNI 25 6 0.005
LVI 8 2 0.19
Positive margin 13 7 0.63
WPOI‐5 Satellite nodules 10 5 0.59
Extratumoral PNI 1 2 0.57
Extratumoral LVI 4 1 0.40
Total 12 5 0.31
Adjuvant treatment None 59 68 < 0.0001
RT 36 3
ChemoRT 3 1

Note: Bold indicates statistical significance.

Table 2 shows factors associated with RR among pN0 patients. For isolated RR, only WPOI‐5 was associated with increased risk (p = 0.02). PORT was associated with reduced risk of isolated RR on the log‐rank test (p = 0.04); however, because none of the patients with isolated RR received PORT, we were not able to calculate the odds ratio. For any RR, non‐cohesive POI and WPOI‐5 were associated with increased risk, while PORT was associated with reduced risk.

TABLE 2.

Risk factors for RR among pN0 patients.

Isolated RR (n = 5) Any RR (n = 7) Log rank test
Odds ratio Log rank test Odds ratio p
Subsite Tongue 2.07 (0.32, 13.40) 0.44 1.55 (0.40, 6.05) 0.53 0.52
LN yield ≤ 18 5.14 (0.57, 46.24) 0.10 2.67 (0.67, 10.73) 0.17 0.15
Non‐cohesive invasive front 5.63 (0.63, 50.40) 0.08 4.92 (1.01, 23.74) 0.047 0.03
Depth of invasion ≤ 5 mm Ref 0.37 Ref Ref 0.51
6–10 mm a 3.06 (0.37, 25.55) 0.30
> 10 mm 1.35 (0.15, 12.19) 3.41 (0.31, 37.78) 0.32
PNI 3.33 (0.47, 23.72) 0.20 3.45 (0.86, 13.90) 0.08 0.06
LVI a 0.52 1.28 (0.16, 10.48) 0.82 0.82
Tumor at margin 3.72 (0.61, 22.47) 0.13 1.62 (0.33, 7.86) 0.55 0.55
WPOI‐5 6.43 (1.06, 39.04) 0.02 8.00 (2.10, 30.44) 0.002 0.0003
PORT a 0.04 6.67 (0.83, 53.78) 0.08 0.04

Note: Bold indicates statistical significance.

a

Unable to calculate odds ratio.

Kaplan–Meier survival curves for any RR and isolated RR according to WPOI‐5 are shown in Figure 1a,b.

FIGURE 1.

FIGURE 1

Kaplan–Meier survival curves for any RR and isolated RR according to WPOI among patients with pN0 necks (Figure 1a and b), and pN0/x necks (Figure 1c and d). [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]

5.2. Recurrences in pN0/x Patients

Because of the small number of events of isolated RR among pN0 patients, we repeated the analysis including both pN0 and pNx patients, that is, cN0 patients who did not undergo ND as part of their primary treatment. Clinicopathological features of pNx patients are shown alongside those of pN0 patients in Table 1. Compared to pN0 patients, pNx patients were older, were more likely to have pT1 primary tumors, with smaller DOI, and with cohesive POI, and were less likely to have PNI or receive adjuvant treatment.

Among this combined group of 170 pN0/x patients, mean (median) follow‐up was 66 (58) months. 15 (8.8%) developed RR, of whom 9 (5.3%) had isolated RR. Isolated RR developed only among patients who did not undergo PORT.

Table 3 shows the association between risk factors and RR. For isolated RR, DOI > 10 mm (p = 0.04), WPOI (p = 0.005), and PORT (p = 0.045) were significant on univariate analysis. On multivariate analysis, only WPOI (OR 5.21, 95% CI 1.24, 21.98) was significant. DOI > 10 mm was just outside significance (OR 4.19, 95% CI 0.96, 18.29). For any RR, non‐cohesive invasive front, DOI > 10 mm, PNI, and WPOI were significantly associated with any RR, while PORT was just outside significance. On multivariate analysis, WPOI (OR 8.53, 95% CI 1.76, 41.41), DOI > 10 mm (OR 9.45, 95% CI 2.63, 33.94), and PORT (OR 0.04, 95% CI 0.004, 0.36) were significant.

TABLE 3.

Risk factors for RR among pN0/x patients.

Isolated RR (n = 9) a Any RR (n = 15)
Odds ratio p Log rank test Odds ratio (95% CI) p Log rank test
Subsite Tongue 1.97 (0.45, 8.70)

0.37

0.36 2.02 (0.66, 6.20) 0.22 0.21
Neck dissection None 1.24 (0.31, 5.04) 0.76 0.76 1.92 (0.69, 5.36) 0.21 0.20
PORT None a a 0.05 0.17 (0.02, 1.29) 0.09 0.05
Non‐cohesive invasive front 3.45 (0.92, 12.97) 0.07 0.05 3.00 (1.08, 8.33) 0.04 0.03
Depth of invasion ≤ 5 mm Ref Ref 0.04 Ref Ref 0.002
6‐10 mm 2.54 (0.46, 14.04) 0.29 1.58 (0.42, 5.95) 0.50
> 10 mm 8.19 (1.28, 52.32) 0.03 7.05 (1.92, 25.92) 0.003
PNI 2.21 (0.43, 11.43) 0.34 0.33 3.40 (1.11, 10.45) 0.03 0.02
LVI a a 0.53 3.45 (0.64, 13.11) 0.17 0.15
Tumor at margin 1.82 (0.37, 8.89) 0.46 0.46 1.01 (0.22, 4.44) 0.99 0.99
WPOI‐5 5.95 (1.45, 24.51) 0.01 0.005 8.19 (2.84, 23.60) < 0.0001 < 0.0001

Note: Bold indicates statistical significance.

a

Unable to calculate odds ratio.

Kaplan–Meier survival curves for any RR and isolated RR according to WPOI among patients with pN0/x necks are shown in Figure 1c,d.

5.3. Survival Among Patients With RR

Among a total of nine patients with isolated RR, seven (including three who had undergone previous ND) underwent further neck surgery. Four were rendered disease‐free, of whom two died from other causes, and two were alive at the time of last follow‐up. Mean survival among patients undergoing successful salvage of isolated RR was 55.3 (30–117) months, versus 4.6 (1–8) months among patients not undergoing successful salvage surgery. Among patients developing simultaneous LR and RR, four (including two who had undergone previous ND) underwent salvage surgery. However, all developed further recurrence and died from cancer. Mean survival after simultaneous LR and RR was 14.1 (1–27) months.

5.4. Risk Factors for Occult Metastases in cN0 Necks

Among 130 cN0 patients undergoing elective ND, occult metastases were detected pathologically in 32 (24.6%). Risk factors for occult metastatic disease on univariate analysis were DOI > 10 mm (p = 0.02), non‐cohesive POI (p = 0.02), PNI (p = 0.03), and LVI (p = 0.008) (Table 4). On multivariate analysis, only LVI (p = 0.03) remained significant.

TABLE 4.

Risk factors for occult metastases in cN0 necks undergoing elective ND.

pN0 (n = 98) pN+ (n = 32) Fisher exact test Multivariate analysis OR (95% CI)
Depth > 5 mm 64 26 0.12
Depth > 10 mm 19 13 0.02 0.32 1.6 (0.6–4.4)
Non‐cohesive Invasive front 44 22 0.02 0.19 1.9 (0.7–4.8)
PNI 25 16 0.03 0.39 1.5 (0.6–4.0)
LVI 8 11 0.0008 0.026 3.6 (1.2–10.9)
Positive margin 13 2 0.36
WPOI‐5 12 6 0.38
Satellite nodules 10 5 0.52
Extratumoral LVI 1 2 0.15
Extratumoral PNI 4 0 0.57

Abbreviations: LVI: lymphovascular invasion, OR: odds ratio, pN+: pathologically node positive, pN0: pathologically node negative, PNI: perineural invasion, WPOI: worst pattern of invasion.

6. Discussion

Theoretically, the risk of RR among patients with early OSCC and pN0 necks should be very low. However, a systematic review and meta‐analysis performed by Chegini et al. reported a mean isolated RR among patients with pN0 necks after elective ND of 13% among patients with OSCC of any T‐classification and 7.5% among patients with T1/2 primary tumors. However, many of the studies included in this review had different endpoints, and most did not specifically analyze risk factors for RR.

Among studies reporting on early OSCC, Ganly et al. reported an isolated RR rate of 14% among a series of 164 patients with pT1/2N0 OSCC treated with surgery alone, without PORT. The only factor predictive of RR was thickness > 4 mm; however, this association was for all RR, including those occurring simultaneous with LR [22]. Liao at al reported on overall RR of 8% among 387 patients with pT1/2 N0 OSCC treated with surgery alone and also reported DOI ≥ 4 mm to be an independent predictor of RR [23]. Low et al. reported on 121 patients with T1N0/x OSCC treated at the Sydney Head and Neck Cancer Institute, who also did not require PORT, and reported thickness > 5 mm, PNI, infiltrative margins, and poor differentiation to be associated with increased risk of RR. However, most patients in this series did not undergo ND, so the findings of this study may not be generalizable to cases with pathologically proven negative necks [24]. Feng et al. reported a 9.5% isolated RR among 116 pT1/2N0 OSCC patients [25]. Lin et al. reported that patients with pN0 necks had lower RR rates (9%) compared with patients with pN+ necks (50%) among patients with pT1/2 tongue SCC; however, in this series, only a minority of patients (29/72) underwent END, and it is not clear whether RR includes cases occurring simultaneous with LR [26]. Thus, risk factors for isolated RR among early OSCC patients with pN0 necks remain unclear. This represents an important gap, as there is increasing interest in avoiding PORT to the neck among patients with indications for PORT based on the primary tumor but who have pN0 necks after elective ND [27, 28].

In the present study, we report an overall incidence of RR of 7.1%, and an incidence of isolated RR of 5.1% among patients with pT1/2N0 OSCC. The most important risk factor for predicting RR was WPOI‐5. WPOI has previously been reported to predict poor outcomes in OSCC, with WPOI‐5 versus patterns 1–4 representing the key significant cut‐point [18, 29, 30, 31]. Li et al. reported WPOI‐5 to significantly correlate with both locoregional recurrence and disease‐specific survival on multivariate analysis in a stage I/II cohort [18], while in a previous study, we found WPOI‐5 to be associated with worse survival in early oral cancer [16]. In the present study, we report WPOI‐5 to be a significant predictor specifically of RR among early OSCC patients with pN0 necks, and an independent predictor of isolated RR among patients with pN0/x necks. In contrast, WPOI‐5 was not significantly associated with occult nodal disease among cN0 patients undergoing elective ND. However, due to the low frequency of WPOI‐5, it is likely we were underpowered to detect such an association. This hypothesis is supported by the finding that the non‐cohesive invasive front, PNI, and LVI, all of which are components of WPOI‐5, were significant for occult nodal deposits.

In the present study, a substantial proportion of RR occurred in the contralateral undissected neck. This is consistent with the findings of Ganly, Low, and Feng [22, 24, 25]. Contralateral nodal recurrence in well‐lateralized OSCC has been reported in up to 6%–16% of patients, but most commonly in node‐positive patients, with particular risk factors being pN2+ disease or extracapsular extension (ECE) [32, 33, 34]. Interestingly, PNI [32, 33] and LVI [32] have been reported as risk factors for contralateral nodal recurrence, but without distinction between intratumoral and extratumoral.

An important difference between our study and those of Ganly [22], Liao [23] and Low [24] was the exclusion in those studies of patients undergoing PORT. It is likely this led to the exclusion also of patients with PNI and LVI, which are component features of WPOI‐5 [22]. In our series, isolated RR occurred only among patients who did not receive PORT. Of note, among patients with OSCC who require PORT based on primary tumor indications, current protocols are for irradiation to both the primary and the neck, even when the neck is pathologically negative [35]. Recently, a multicentre clinical trial (NCT03997643) randomizing patients with pN0 necks to the standard of care arm with PORT to all dissected areas, or to an experimental arm with omission of PORT to the pN0 neck has completed accrual [27]. Although our study does not provide evidence that PORT may reduce the risk of RR among patients with WPOI‐5, our findings might suggest that patients with WPOI‐5 may not be good candidates for adjuvant therapy de‐escalation, even if they have pN0 necks.

Reasons for the development of isolated RR after pN0 ND are unclear. Chegini suggested that isolated RR in pN0 neck represented a true failure of END to detect nodal disease, which could be due to inadequate surgical nodal clearance, skip metastases to undissected levels, or deficient pathological analysis [21]. Regarding skip metastases, recurrence outside dissected levels in the dissected neck is reported to be rare [22, 36], even among cases with cN+ necks [37]. However, it is possible that inadequate surgical clearance may risk leaving occult metastases in situ, which may give rise to RR. In support of this hypothesis, a number of authors have reported that among patients with pN0 necks, a lymph node yield ≤ 18 is associated with worse outcome [38, 39], although these associations were with locoregional recurrence (LRR) [39] and survival [38, 39] rather than RR specifically. In the present study, we did see separation of the Kaplan–Meier survival curves for RR between patients with lymph node yield ≤ 18 and > 18; however, the difference was not significant, which may be due to underpowering. The other possibility is pathological failure to detect metastases. Amit et al. demonstrated that among pN0 patients where the radiological review was suspicious of cervical nodal metastases, pathological re‐review demonstrated that the original pathological report was falsely negative in 15% [40], while Ganly et al. reported that 7/52 neck dissection specimens reported as negative contained micrometastases on review [22]. Of note, a large proportion of true isolated RR in this study, as well as the studies of Ganly [22] and Low [24], occurred on the contralateral neck, and the reasons for isolated contralateral RR in these cases remain unclear.

Recently, sentinel node biopsy (SNB) as an alternative to elective ND has become increasingly popular in OSCC management. Notably, late neck failure rates after SNB appear to be higher (9.3%–14%) [41, 42] than false negative rates when patients undergo simultaneous SNB and ND (3%–5%) [43, 44]. Further work is required to ascertain whether WPOI‐5 may be a risk factor for late neck failure after negative SNB. One advantage of SNB is the ability to detect contralateral neck drainage [41], but as yet, it is unknown whether this has the potential to obviate contralateral neck RR seen among patients with ipsilateral pN0 necks.

Weaknesses of the paper include the retrospective nature and the small number of events of isolated RR, which likely made our paper underpowered to detect significant associations between variables besides WPOI and isolated RR. We tried to minimize this by repeating the analysis on a larger cohort including pNx patients. This latter group should have a lower risk of cervical metastases than patients undergoing ND based on the lower incidence of risk factors for metastases in this group; however, we cannot discount the possibility that some of these cases may have had occult metastases at the time of surgery that were missed by not having performed ND. A further consideration regarding the generalizability of our results is the possibility of differences in patient cohorts due to institutional differences in treatment protocol. For example, at our institution, END is generally performed as default among medically fit patients excepting those with very thin tumors. Thus, our findings may not be applicable to series where END is performed more selectively in early OSCC [10, 26]. Other institutional differences may include indicators for PORT and whether this is administered to unilateral or bilateral necks. On the other hand, strengths of the study include the systematic slide review for determination of DOI and WPOI‐5, as well as the distinction between isolated RR and locoregional control as outcome measures.

7. Conclusion

In excess of 5% of patients with early OSCC and pathologically negative necks after elective ND may develop RR, even in the absence of demonstrable LR or SPT. WPOI‐5 is emerging as an important adverse prognosticator in early OSCC, and was found in the present study to be the main risk factor predictive of isolated RR. Further work is required to define the role of cervical PORT among patients with WPOI‐5 without other adverse prognosticators.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

The authors have nothing to report.

Hintze J., van den Berg N., Callanan D., Mohamed S., Feeley L., and Sheahan P., “Impact of WPOI‐5 on Risk of Regional Recurrence in Early Oral Cancer With pN0 Neck,” The Laryngoscope 135, no. 9 (2025): 3213–3221, 10.1002/lary.32182.

Funding: The authors received no specific funding for this work.

References

  • 1. Ho A. S., Kim S., Tighiouart M., et al., “Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer,” Journal of Clinical Oncology 35, no. 31 (2017): 3601–3609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Noguti J., De Moura C. F., De Jesus G. P., et al., “Metastasis From Oral Cancer: An Overview,” Cancer Genomics & Proteomics 9, no. 5 (2012): 329–335. [PubMed] [Google Scholar]
  • 3. Werning J. W., Heard D., Pagano C., and Khuder S., “Elective Management of the Clinically Negative Neck by Otolaryngologists in Patients With Oral Tongue Cancer,” Archives of Otolaryngology – Head & Neck Surgery 129, no. 1 (2003): 83–88. [DOI] [PubMed] [Google Scholar]
  • 4. D'Cruz A. K., Vaish R., Kapre N., et al., “Elective Versus Therapeutic Neck Dissection in Node‐Negative Oral Cancer,” New England Journal of Medicine 373, no. 6 (2015): 521–529. [DOI] [PubMed] [Google Scholar]
  • 5. Fasunla A. J., Greene B. H., Timmesfeld N., Wiegand S., Werner J. A., and Sesterhenn A. M., “A Meta‐Analysis of the Randomized Controlled Trials on Elective Neck Dissection Versus Therapeutic Neck Dissection in Oral Cavity Cancers With Clinically Node‐Negative Neck,” Oral Oncology 47, no. 5 (2011): 320–324. [DOI] [PubMed] [Google Scholar]
  • 6. International Consortium for Outcome Research in H , Neck C., Ebrahimi A., et al., “Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,” JAMA Otolaryngology. Head & Neck Surgery 140, no. 12 (2014): 1138–1148. [DOI] [PubMed] [Google Scholar]
  • 7. Jardim J. F., Francisco A. L., Gondak R., Damascena A., and Kowalski L. P., “Prognostic Impact of Perineural Invasion and Lymphovascular Invasion in Advanced Stage Oral Squamous Cell Carcinoma,” International Journal of Oral and Maxillofacial Surgery 44, no. 1 (2015): 23–28. [DOI] [PubMed] [Google Scholar]
  • 8. Brandwein‐Gensler M., Teixeira M. S., Lewis C. M., et al., “Oral Squamous Cell Carcinoma: Histologic Risk Assessment, but Not Margin Status, Is Strongly Predictive of Local Disease‐Free and Overall Survival,” American Journal of Surgical Pathology 29, no. 2 (2005): 167–178, 10.1097/01.pas.0000149687.90710.21. [DOI] [PubMed] [Google Scholar]
  • 9. Goodman M., Liu L., Ward K., et al., “Invasion Characteristics of Oral Tongue Cancer: Frequency of Reporting and Effect on Survival in a Population‐Based Study,” Cancer 115, no. 17 (2009): 4010–4020. [DOI] [PubMed] [Google Scholar]
  • 10. Huang T. Y., Hsu L. P., Wen Y. H., et al., “Predictors of Locoregional Recurrence in Early Stage Oral Cavity Cancer With Free Surgical Margins,” Oral Oncology 46, no. 1 (2010): 49–55. [DOI] [PubMed] [Google Scholar]
  • 11. Sandu K., Nisa L., Monnier P., Simon C., Andrejevic‐Blant S., and Bron L., “Clinicobiological Progression and Prognosis of Oral Squamous Cell Carcinoma in Relation to the Tumor Invasive Front: Impact on Prognosis,” Acta Oto‐Laryngologica 134, no. 4 (2014): 416–424. [DOI] [PubMed] [Google Scholar]
  • 12. W. L. Hicks, Jr. , Loree T. R., Garcia R. I., et al., “Squamous Cell Carcinoma of the Floor of Mouth: A 20‐Year Review,” Head & Neck 19 (1997): 400. [DOI] [PubMed] [Google Scholar]
  • 13. Rogers S. N., Brown J. S., Woolgar J. A., et al., “Survival Following Primary Surgery for Oral Cancer,” Oral Oncology 45, no. 3 (2009): 201–211. [DOI] [PubMed] [Google Scholar]
  • 14. Brinkman D., Callanan D., Jawad H., et al., “Comparison of Royal College of Pathologists and College of American Pathologists Definition for Positive Margins in Oral Cavity Squamous Cell Carcinoma,” Oral Oncology 127 (2022): 105797, 10.1016/j.oraloncology.2022.105797. [DOI] [PubMed] [Google Scholar]
  • 15. Fives C., Feeley L., O'Leary G., and Sheahan P., “Importance of Lymphovascular Invasion and Invasive Front on Survival in Floor of Mouth Cancer,” Head & Neck 38, no. S1 (2016): E1528–E1534. [DOI] [PubMed] [Google Scholar]
  • 16. Mohamed S., Jawad H., Sullivan R. O., Callanan D., Sheahan P., and Feeley L., “Significance of Worst Pattern of Invasion‐5 in Early‐Stage Oral Cavity Squamous Cell Carcinoma,” Head and Neck Pathology 17, no. 3 (2023): 679–687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kligerman M. P., Moon P. K., Tusty M., et al., “Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma,” Annals of Otology, Rhinology, and Laryngology 132, no. 7 (2023): 731–737. [DOI] [PubMed] [Google Scholar]
  • 18. Li Y., Bai S., Carroll W., et al., “Validation of the Risk Model: High‐Risk Classification and Tumor Pattern of Invasion Predict Outcome for Patients With Low‐Stage Oral Cavity Squamous Cell Carcinoma,” Head and Neck Pathology 7, no. 3 (2013): 211–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Seethala R. R., Weinreb I., Bullock M. J., et al., “Protocol for the Examination of Specimens From Patients With Carcinomas of the Lip and Oral Cavity Version 4.1.0.0. College of American Pathologists (CAP),” https://documents.cap.org/protocols/HN.LipOral_4.1.0.0.REL_CAPCP.pdf.
  • 20. Hunter K., Da Forno P., Hall G., Jones A., and G T., “Standards and Datasets for Reporting Cancers Dataset for the Histopathological Reporting of Carcinomas of the Oral Cavity,” accessed 23 July 2024, 2023, The Royal College of Pathologists, https://www.rcpath.org/static/c4a9faf7‐393a‐4ba8‐9532f719d8cdff3b/7b0a5709‐ce18‐4694‐8e4c84a4ffd466f2/Dataset‐for‐histopathology‐reporting‐of‐carcinomas‐of‐the‐oral‐cavity.pdf.
  • 21. Chegini S., Schilling C., Walgama E. S., et al., “Neck Failure Following Pathologically Node‐Negative Neck Dissection (pN0) in Oral Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis,” British Journal of Oral & Maxillofacial Surgery 59, no. 10 (2021): 1157–1165. [DOI] [PubMed] [Google Scholar]
  • 22. Ganly I., Goldstein D., Carlson D. L., et al., “Long‐Term Regional Control and Survival in Patients With ‘Low‐Risk,’ Early Stage Oral Tongue Cancer Managed by Partial Glossectomy and Neck Dissection Without Postoperative Radiation: The Importance of Tumor Thickness,” Cancer 119, no. 6 (2013): 1168–1762. [DOI] [PubMed] [Google Scholar]
  • 23. Liao C. T., Lin C. Y., Fan K. H., et al., “Identification of a High‐Risk Group Among Patients With Oral Cavity Squamous Cell Carcinoma and pT1‐2N0 Disease,” International Journal of Radiation Oncology, Biology, Physics 82, no. 1 (2012): 284–290. [DOI] [PubMed] [Google Scholar]
  • 24. Low T. H., Gao K., Gupta R., et al., “Factors Predicting Poor Outcomes in T1N0 Oral Squamous Cell Carcinoma: Indicators for Treatment Intensification,” ANZ Journal of Surgery 86, no. 5 (2016): 366–371, 10.1111/ans.13504. [DOI] [PubMed] [Google Scholar]
  • 25. Feng Z., Li J. N., Li C. Z., and Guo C. B., “Elective Neck Dissection Versus Observation in the Management of Early Tongue Carcinoma With Clinically Node‐Negative Neck: A Retrospective Study of 229 Cases,” Journal of Cranio‐Maxillo‐Facial Surgery 42, no. 6 (2014): 806–810. [DOI] [PubMed] [Google Scholar]
  • 26. Lin M. J., Guiney A., Iseli C. E., Buchanan M., and Iseli T. A., “Prophylactic Neck Dissection in Early Oral Tongue Squamous Cell Carcinoma 2.1 to 4.0 Mm Depth,” Otolaryngology and Head and Neck Surgery 144, no. 4 (2011): 542–548. [DOI] [PubMed] [Google Scholar]
  • 27. Lang P., Contreras J., Kalman N., et al., “Preservation of Swallowing in Resected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): Study Protocol for a Randomized Phase II Trial,” Radiation Oncology 15, no. 1 (2020): 196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. So Y. K., Oh D., Choi N., Baek C. H., Ahn Y. C., and Chung M. K., “Efficacy of Postoperative Neck Irradiation for Regional Control in Patients With pN0 Oral Tongue Cancer: Propensity Analysis,” Head & Neck 40, no. 1 (2018): 163–169. [DOI] [PubMed] [Google Scholar]
  • 29. Brandwein‐Gensler M., Smith R. V., Wang B., et al., “Validation of the Histologic Risk Model in a New Cohort of Patients With Head and Neck Squamous Cell Carcinoma,” American Journal of Surgical Pathology 34, no. 5 (2010): 676–688, 10.1097/PAS.0b013e3181d95c37. [DOI] [PubMed] [Google Scholar]
  • 30. Xu B., Salama A. M., Valero C., et al., “The Prognostic Role of Histologic Grade, Worst Pattern of Invasion, and Tumor Budding in Early Oral Tongue Squamous Cell Carcinoma: A Comparative Study,” Virchows Archiv 479, no. 3 (2021): 597–606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Chatterjee D., Bansal V., Malik V., et al., “Tumor Budding and Worse Pattern of Invasion Can Predict Nodal Metastasis in Oral Cancers and Associated With Poor Survival in Early‐Stage Tumors,” Ear, Nose, & Throat Journal 98, no. 7 (2019): E112–E119. [DOI] [PubMed] [Google Scholar]
  • 32. Swain M., Budrukkar A., Murthy V., et al., “Contralateral Nodal Relapse in Well‐Lateralised Oral Cavity Cancers Treated Uniformly With Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: A Retrospective Study,” Clinical Oncology 36, no. 5 (2024): 278–286. [DOI] [PubMed] [Google Scholar]
  • 33. Chien J. C., Hu Y. C., Chang K. C., et al., “Contralateral Lymph Node Recurrence Rate and Its Prognostic Factors in Stage IVA‐B Well‐Lateralized Oral Cavity Cancer,” Auris, Nasus, Larynx 48, no. 5 (2021): 991–998. [DOI] [PubMed] [Google Scholar]
  • 34. Razavian N. B., Shenker R. F., D'Agostino R. B., and Hughes R. T., “Association of Ipsilateral Radiation Therapy With Contralateral Lymph Node Failure in Patients With Squamous Cell Carcinoma of the Oral Cavity: A Systematic Review and Meta‐Analysis,” Head & Neck 45, no. 8 (2023): 1967–1974, 10.1002/hed.27421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Biau J., Lapeyre M., Troussier I., et al., “Selection of Lymph Node Target Volumes for Definitive Head and Neck Radiation Therapy: A 2019 Update,” Radiotherapy and Oncology 134 (2019): 1–9. [DOI] [PubMed] [Google Scholar]
  • 36. Obermeier K. T., Liokatis P., Haidari S., Kakoschke T. K., Kraus M., and Smolka W., “Lymph Nodal Recurrence in Levels IV and V in Oral Squamous Cell Carcinoma After Neck Dissection,” ANZ Journal of Surgery 93, no. 6 (2023): 1688–1693. [DOI] [PubMed] [Google Scholar]
  • 37. Altawil M., Stanisz I., Van Den Berg N. H., and Sheahan P., “Pattern of Regional Recurrence After Selective Neck Dissection for Clinically Positive Neck in Mucosal Squamous Carcinoma,” Head & Neck 46, no. 10 (2024): 2464–2472. [DOI] [PubMed] [Google Scholar]
  • 38. Zenga J., Divi V., Stadler M., et al., “Lymph Node Yield, Depth of Invasion, and Survival in Node‐Negative Oral Cavity Cancer,” Oral Oncology 98 (2019): 125–131. [DOI] [PubMed] [Google Scholar]
  • 39. Farrokhian N., Holcomb A. J., Dimon E., et al., “Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node‐Negative Oral Cavity Squamous Cell Carcinoma,” JAMA Otolaryngology. Head & Neck Surgery 148, no. 10 (2022): 947–955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Amit M., Yen T. C., Liao C. T., et al., “The Origin of Regional Failure in Oral Cavity Squamous Cell Carcinoma With Pathologically Negative Neck Metastases,” JAMA Otolaryngology. Head & Neck Surgery 140, no. 12 (2014): 1130–1137. [DOI] [PubMed] [Google Scholar]
  • 41. Schilling C., Stoeckli S. J., Haerle S. K., et al., “Sentinel European Node Trial (SENT): 3‐Year Results of Sentinel Node Biopsy in Oral Cancer,” European Journal of Cancer 51, no. 18 (2015): 2777–2784. [DOI] [PubMed] [Google Scholar]
  • 42. Garrel R., Poissonnet G., Moyà Plana A., et al., “Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1‐T2N0 Oral and Oropharyngeal Cancer,” Journal of Clinical Oncology 38, no. 34 (2020): 4010–4018. [DOI] [PubMed] [Google Scholar]
  • 43. Abdul‐Razak M., Mwagiru D., Veness M., Wong E., Pang T., and Morgan G., “Does Sentinel Lymph Node Biopsy Accurately Stage the Clinically Negative Neck in Early Oral Cavity Squamous Cell Carcinoma?,” Journal of Oral and Maxillofacial Surgery 80, no. 6 (2022): 1134–1142. [DOI] [PubMed] [Google Scholar]
  • 44. Civantos F. J., Zitsch R. P., Schuller D. E., et al., “Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1‐T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi‐Institutional Trial,” Journal of Clinical Oncology 28, no. 8 (2010): 1395–1400. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Laryngoscope are provided here courtesy of Wiley

RESOURCES